A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
The case in favour of probiotics before, during and after pregnancy: insights from the first 1,500 days
Tekijät: Reid G, Kumar H, Khan AI, Rautava S, Tobin J, Salminen S
Kustantaja: WAGENINGEN ACADEMIC PUBLISHERS
Julkaisuvuosi: 2016
Journal: Beneficial Microbes
Tietokannassa oleva lehden nimi: BENEFICIAL MICROBES
Lehden akronyymi: BENEF MICROBES
Vuosikerta: 7
Numero: 3
Aloitussivu: 353
Lopetussivu: 362
Sivujen määrä: 10
ISSN: 1876-2883
DOI: https://doi.org/10.3920/BM2015.0140
Tiivistelmä
Successful human reproduction requires microbial homeostasis in the female reproductive tract, and colonisation of the newborn with beneficial microbes. In order to prevent several complications associated with dysbiosis, the administration of probiotics is more often being considered. The objective of the enclosed review was to examine the rationale for probiotic utility before and during pregnancy and in the early phase of infant life. The conclusions emerged from a panel of researchers who met during the International Scientific Association for Probiotics and Prebiotics (ISAPP) workshop held in Washington, DC, USA in 2015. The group concluded based upon the current literature, that a case can be made for the use of a specific sets of probiotic organisms during the first 1,500 days of life, with the goal of a healthy pregnancy to term, and a healthy start to life with lowered risk of infections and inflammatory events. The key to successfully translating these recommendations to practice is that products be made available and affordable to women in developed and developing countries.
Successful human reproduction requires microbial homeostasis in the female reproductive tract, and colonisation of the newborn with beneficial microbes. In order to prevent several complications associated with dysbiosis, the administration of probiotics is more often being considered. The objective of the enclosed review was to examine the rationale for probiotic utility before and during pregnancy and in the early phase of infant life. The conclusions emerged from a panel of researchers who met during the International Scientific Association for Probiotics and Prebiotics (ISAPP) workshop held in Washington, DC, USA in 2015. The group concluded based upon the current literature, that a case can be made for the use of a specific sets of probiotic organisms during the first 1,500 days of life, with the goal of a healthy pregnancy to term, and a healthy start to life with lowered risk of infections and inflammatory events. The key to successfully translating these recommendations to practice is that products be made available and affordable to women in developed and developing countries.
Turun yliopiston Tutkimustietojärjestelmän portaali